Find Information About:

Drugs & Supplements

Get information and reviews on prescription drugs, over-the-counter medications, vitamins, and supplements. Search by name or medical condition.

Pill Identifier

Pill Identifier

Having trouble identifying your pills?

Enter the shape, color, or imprint of your prescription or OTC drug. Our pill identification tool will display pictures that you can compare to your pill.

Get Started

My Medicine

Save your medicine, check interactions, sign up for FDA alerts, create family profiles and more.

Get Started

WebMD Health Experts and Community

Talk to health experts and other people like you in WebMD's Communities. It's a safe forum where you can create or participate in support groups and discussions about health topics that interest you.

  • Second Opinion

    Second Opinion

    Read expert perspectives on popular health topics.

  • Community


    Connect with people like you, and get expert guidance on living a healthy life.

Got a health question? Get answers provided by leading organizations, doctors, and experts.

Get Answers

Sign up to receive WebMD's award-winning content delivered to your inbox.

Sign Up

HIV & AIDS Health Center

Font Size

Confidentiality in HIV Testing Remains Controversial

WebMD Health News

Nov. 10, 1999 (Chicago) -- If agencies that test for HIV have to name names, at-risk people may shy away from testing. On the other hand, being named may make no difference at all. Speakers in a panel here at the 127th annual meeting of the American Public Health Association shared studies whose findings yielded different results about the importance of confidentiality in HIV testing and treatment.

"Confidentiality has been controversial, and will continue to be in the future," moderator Richard R. Sun, MD, MPH, tells WebMD. "Some of the studies show that confidentiality can promote people's willingness to be tested; therefore, it leads to increased partner notification. Another study shows that the number of people being tested has not declined in a state that requires the reporting of names. Physicians need to be knowledgeable about HIV-related confidentiality issues in their states, because the liability issues vary with each state's confidentiality and reporting requirements." Sun is chief of the HIV/AIDS epidemiology branch of the California Department of Health Services in Sacramento.

"In our survey ... respondents who are at high risk [for HIV], and those who are HIV-positive, are more concerned about confidentiality than are low-risk respondents," Liza Solomon, DrPH, and director of AIDS administration for the Maryland Department of Health in Baltimore, tells WebMD. "With each level of lower confidentiality, fewer people were willing to be tested," she says.

Solomon and colleagues conducted telephone surveys of about 270 subjects. Among all participants, testing where no names are used, also called anonymous testing, was the option that was most likely to be accepted; 93% of low-risk and 89% of high-risk respondents expressed willingness to be tested under such circumstances. The testing option that required reporting of names to government agencies was the least favorable. Only 67% of low-risk and 64% of high-risk respondents accepted it.

However, does the elimination of names actually cause a decline in testing? Perhaps not, according to a study presented by Brian Castrucci, a PhD candidate in public health at Columbia University in New York. In a study of HIV testing patterns in North Carolina, he and colleagues found a decline of only 5% being tested between the year before and the year after the state dropped anonymous testing.

Today on WebMD

How much do you know?
contemplative man
What to do now.
Should you be tested?
HIV under microscope
What does it mean?
HIV AIDS Screening
man opening condom wrapper
HIV AIDS Treatment
Discrimination Stigma
Treatment Side Effects
grilled chicken and vegetables
obese man standing on scale
cold sore